Our Culture of Innovation

Since 1966, Groupe Grimaud companies have been using emerging new technologies in their animal breeding programs.

In 2011, this scheme of development has been strengthened by launching a distinctive innovation approach, similar to the technological developments used in other fields such as human health (medical imaging), mobility (electric motors), energy (renewable energies), telephony (with the smartphones), etc... Still using the support of our existing tools, we opted to value and adapt tools coming from other sectors to our activities. This is why Groupe Grimaud qualifies its policy of innovation as "GeneTech by Grimaud" or Distinctive Innovation.

.

Sustainability
Quality
Security
Environment
Animal welfare

Our 5 commitments

Groupe Grimaud is one of the first parts of the value chain in animal production, offering a significant added value to the other players in the industry up to the consumer level. That is why the GeneTech approach is realised by respecting 5 fundamental commitments, namely: always supply the industry with more competitive products, in a sustainable way respecting the environment and animal welfare, and assuring the customers of products combining high quality with undisputable sanitary status.

Conviction #1

Imaging by scanner

Look
inside,

See
further

Scanner : our approach

BENEFIT #1: Imaging by scanner

GeneTech is based on different benefits. As we will communicate more on GeneTech, we encourage you to discover the benefits of each of our innovative tool.

Know more about it

In figures

Groupe Grimaud

The mission of the Groupe Grimaud is to further develop know-how and products in the life science field, contributing to the development of efficient solutions for the food and health industries throughout the world.

Our two core businesses are :

  • Genetic selection, production and distribution of animal breeding stock, hatching eggs and semen for broiler and layer chickens, pigs, ducks, guinea fowls, rabbits, pigeons and shrimps.
  • Bio-pharmacy serving human and animal health through vaccines, pharmaceutical proteins and sera, human antibodies, specific pathogen free animals, bacterial cultures.